MARIOTTO, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 3.109
AS - Asia 2.372
EU - Europa 969
SA - Sud America 411
AF - Africa 305
Continente sconosciuto - Info sul continente non disponibili 67
OC - Oceania 36
Totale 7.269
Nazione #
US - Stati Uniti d'America 2.887
SG - Singapore 736
CN - Cina 465
VN - Vietnam 288
HK - Hong Kong 278
BR - Brasile 269
IT - Italia 257
BD - Bangladesh 108
DE - Germania 100
IN - India 83
FI - Finlandia 76
FR - Francia 70
PL - Polonia 66
CA - Canada 53
GB - Regno Unito 49
RU - Federazione Russa 38
JP - Giappone 37
TR - Turchia 36
AR - Argentina 33
NL - Olanda 32
KR - Corea 26
MX - Messico 24
UA - Ucraina 23
EC - Ecuador 22
SA - Arabia Saudita 22
UZ - Uzbekistan 22
BJ - Benin 21
SE - Svezia 21
ID - Indonesia 19
IQ - Iraq 19
MY - Malesia 19
ES - Italia 18
RO - Romania 18
ZA - Sudafrica 18
AT - Austria 17
GF - Guiana Francese 17
PH - Filippine 17
PK - Pakistan 16
JM - Giamaica 14
PY - Paraguay 14
VE - Venezuela 14
AZ - Azerbaigian 12
CO - Colombia 12
GP - Guadalupe 12
ML - Mali 12
TH - Thailandia 12
TN - Tunisia 12
TW - Taiwan 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
CM - Camerun 11
CR - Costa Rica 11
EE - Estonia 11
GR - Grecia 11
HN - Honduras 11
JO - Giordania 11
KE - Kenya 11
LA - Repubblica Popolare Democratica del Laos 11
LB - Libano 11
NI - Nicaragua 11
NZ - Nuova Zelanda 11
BZ - Belize 10
DK - Danimarca 10
ET - Etiopia 10
GH - Ghana 10
IE - Irlanda 10
KG - Kirghizistan 10
PE - Perù 10
SI - Slovenia 10
SO - Somalia 10
ZM - Zambia 10
AL - Albania 9
BG - Bulgaria 9
CG - Congo 9
CZ - Repubblica Ceca 9
DZ - Algeria 9
GA - Gabon 9
GT - Guatemala 9
HU - Ungheria 9
BF - Burkina Faso 8
BW - Botswana 8
BY - Bielorussia 8
CU - Cuba 8
CV - Capo Verde 8
LU - Lussemburgo 8
MK - Macedonia 8
MW - Malawi 8
NC - Nuova Caledonia 8
AM - Armenia 7
BA - Bosnia-Erzegovina 7
GN - Guinea 7
IL - Israele 7
IR - Iran 7
MA - Marocco 7
MD - Moldavia 7
MZ - Mozambico 7
NO - Norvegia 7
PA - Panama 7
PR - Porto Rico 7
PS - Palestinian Territory 7
Totale 6.917
Città #
Ashburn 452
Singapore 450
San Jose 358
Hong Kong 256
Fairfield 209
Santa Clara 123
Chandler 114
Woodbridge 112
Seattle 105
Los Angeles 99
Cambridge 91
Houston 90
Beijing 85
Ho Chi Minh City 85
Hanoi 70
Ann Arbor 68
Wilmington 61
Munich 47
Council Bluffs 42
Helsinki 42
Boardman 39
San Diego 32
Bytom 31
New York 31
Lauterbourg 30
Hefei 26
Padova 26
Princeton 26
Tokyo 26
Des Moines 25
Buffalo 24
Medford 24
Warsaw 24
Chicago 21
Tashkent 21
Orem 20
Roxbury 20
São Paulo 20
Cotonou 19
Guangzhou 19
Rome 19
Turku 17
Haiphong 16
Milan 16
Da Nang 15
London 15
Seoul 15
Dallas 14
Padua 14
The Dalles 14
Montreal 13
Baku 12
Chennai 12
Toronto 12
Vienna 12
Bamako 11
Denver 11
Lappeenranta 11
Amman 10
Belo Horizonte 10
Bishkek 10
Cayenne 10
Lusaka 10
Managua 10
Nairobi 10
Accra 9
Addis Ababa 9
Cagliari 9
Dong Ket 9
Dublin 9
Hải Dương 9
Istanbul 9
Jinan 9
North York 9
Santiago 9
Tianjin 9
Vientiane 9
Brooklyn 8
Frankfurt am Main 8
Guayaquil 8
Les Abymes 8
Libreville 8
Miami 8
Naples 8
Noumea 8
Ouagadougou 8
Phoenix 8
Poplar 8
Stockholm 8
Auckland 7
Brasília 7
Conakry 7
Dakar 7
Guatemala City 7
Havana 7
Jeddah 7
Johannesburg 7
Kingston 7
Ljubljana 7
Nanjing 7
Totale 4.063
Nome #
AKR1C enzymes sustain therapy resistance in paediatric T-ALL 294
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 281
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 273
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 272
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 267
Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib 258
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities 247
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors 245
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems 238
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein 236
BAG1 down-regulation increases chemo-sensitivity of acute lymphoblastic leukaemia cells 235
A BAG's life: Every connection matters in cancer 224
Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors 218
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities 214
TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy 214
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 212
Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration 209
In vitro and in vivo antitumor activity of new choline kinase inhibitor: a pharmacological strategy for breast cancer and leukemia treatment. 208
Cinnamic acid derivatives linked to arylpiperazines as novel potent inhibitors of tyrosinase activity and melanin synthesis 204
A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents 202
Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents 197
Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma 189
Anticancer and structure activity relationship of non-symmetrical choline kinase inhibitors 189
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors 188
Histone Deacetylase Inhibitors Impair Glioblastoma Cell Motility and Proliferation 187
Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism 185
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action 183
Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents 176
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1 174
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action 158
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 152
Design and synthesis of potent in vitro and in vivo anticancer agents based on 1-(3',4',5'-trimethoxyphenyl)-2-Aryl-1H-imidazole 142
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1) 127
HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion 91
Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives 80
NFATc1 and NFATc2 regulate glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia through modulation of cholesterol biosynthesis and the WNT/β-catenin pathway 69
TrkA activation sustains chemotherapy resistance in chemotolerant medulloblastoma cells 13
Fragment-based discovery of novel small molecule targeting human BAG3 12
Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach 6
Totale 7.269
Categoria #
all - tutte 20.824
article - articoli 20.288
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.112


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022359 0 7 69 15 21 20 30 46 20 22 41 68
2022/2023272 48 21 2 34 31 42 4 19 30 15 22 4
2023/2024211 5 39 27 25 17 7 19 9 8 16 17 22
2024/20251.129 6 112 39 49 138 31 98 111 83 42 163 257
2025/20264.333 271 281 427 643 404 199 656 360 439 277 225 151
2026/2027191 187 4 0 0 0 0 0 0 0 0 0 0
Totale 7.269